| Literature DB >> 24406620 |
Yan Deng1, Chi Chiu Wang2, Kwong Wai Choy1, Quan Du3, Jiao Chen2, Qin Wang4, Lu Li2, Tony Kwok Hung Chung2, Tao Tang5.
Abstract
During recent decades there have been remarkable advances in biology, in which one of the most important discoveries is RNA interference (RNAi). RNAi is a specific post-transcriptional regulatory pathway that can result in silencing gene functions. Efforts have been done to translate this new discovery into clinical applications for disease treatment. However, technical difficulties restrict the development of RNAi, including stability, off-target effects, immunostimulation and delivery problems. Researchers have attempted to surmount these barriers and improve the bioavailability and safety of RNAi-based therapeutics by optimizing the chemistry and structure of these molecules. This paper aimed to describe the principles of RNA interference, review the therapeutic potential in various diseases and discuss the new strategies for in vivo delivery of RNAi to overcome the challenges.Keywords: Gene-silencing; RNA interference; RNAi delivery; Therapeutics
Mesh:
Substances:
Year: 2014 PMID: 24406620 DOI: 10.1016/j.gene.2013.12.019
Source DB: PubMed Journal: Gene ISSN: 0378-1119 Impact factor: 3.688